(Q39688007)

English

The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly

scientific article published on January 1, 1979

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

author name string

F. Roelfsema

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

B. M. Goslings

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

M. Frölich

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

A. J. Moolenaar

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

A. P. Seters

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

H. Van Slooten

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A114344

28 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=114344

28 November 2022

publication date

1 January 1979

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1979.tb03069.x

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1979.tb03069.x/fullpdf

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

235-244

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Bromocriptine therapy in acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1979.TB03069.X

21 January 2018

Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly

1

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Long-term Treatment of Acromegaly with Bromocryptine: Postprandial HGH Levels and Response to TRH and Glucose Administration

2

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Effect of Apomorphine on Growth Hormone Release in Humans1

3

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Effect of Five Dopaminergic Drugs on Plasma Growth Hormone Levels in Acromegalic Subjects

4

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Sleep-Related Growth Hormone Release Following 2-Bromo-α-Ergocriptine Treatment in Acromegalic Patients

5

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Stable Reduction of Plasma Growth Hormone (hGH) Levels During Chronic Administration of 2-Br-α-ergocryptine (CB-154) in Acromegalic Patients

6

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Measurement of the 24 hour integrated plasma concentration of growth hormone, in assessing the response of acromegalic patients to treatment

7

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Growth hormone and the steroid binding -globulin of human plasma

8

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly

9

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses

10

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Serum FSH rise induced by CB-154 (2-Br-alpha-ergocryptine) in postpartum women

12

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Bromocriptine treatment of acromegaly

13

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Long-term treatment of acromegaly with bromocriptine

14

1 reference

10.1111/J.1365-2265.1979.TB03069.X

https://api.crossref.org/works/10.1111/J.1365-2265.1979.TB03069.X

28 November 2022

Identifiers

10.1111/J.1365-2265.1979.TB03069.X

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39688007&oldid=1780276903"